EXPERT COMMENTARY: Communication between Psychiatrists and Patients Regarding Placebo and Nocebo

Abstract

In this insightful commentary, Prof. Dr. Michael Davidson delves into the nuanced dynamics of placebo and nocebo effects in psychiatric treatments, with a focus on communication strategies between psychiatrists and patients. He explores the balance required in presenting the benefits and potential adverse effects of psychotropic drugs while enhancing therapeutic outcomes and minimizing nocebo risks.

The commentary highlights the critical role of non-specific factors such as physician communication, patient conditioning, and natural disease progression in amplifying treatment efficacy. Prof. Davidson also underscores the ethical and practical dilemmas faced by psychiatrists in daily practice, such as the fine line between full disclosure and mitigating nocebo effects, especially in conditions like Major Depressive Disorder (MDD), where placebo response can significantly influence outcomes. By examining established and emerging treatments, including SSRIs, ECT, and psychedelics, Prof. Davidson offers a comprehensive perspective on the evolving clinical skills required to manage placebo and nocebo effects effectively, ensuring both adherence to ethical standards and the best possible patient care.